Drug Approval | March 21, 2022
Alembic Pharmaceuticals receives USFDA approval for Lacosamide tablets
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
The generic version of Sinequan, which is used for the treatment of anxiety, depression, and other target symptoms of psychoneurosis
Macitentan tablets, 10 mg have an estimated market size of US $ 797 million for twelve months ending Dec 2021 according to IQVIA
The product will be manufactured at Lupin’s facility in Goa, India
Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis
The product will be manufactured at Lupin’s facility in Pithampur, India
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
It has a total of 50 ANDA approvals from USFDA
Subscribe To Our Newsletter & Stay Updated
